12:00 AM
 | 
Aug 27, 2012
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

NanoViricides preclinical data

In mice lethally infected with H1N1 influenza virus, a once-daily oral FluCide candidate led to a survival time of 347.4 hours compared to 376.8 hours with IV FluCide every other day and 181.7...

Read the full 154 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >